Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Urothelial Carcinoma of the Bladder × Transurethral Resection of Bladder × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Urinary Bladder Neoplasms 3 Glioblastoma 2 Urothelial Carcinoma of the Bladder 1 Prostatic Hyperplasia 1 Muscle-invasive Urothelial Cancer of the Bladder 1 Glioma 1 Craniopharyngioma 1 Brain Neoplasms 1

Interventions

Vinblastine 1 Transurethral Resection of Bladder 1 Radiotherapy, Intensity-Modulated 1 Mitomycin 1 Methotrexate 1 Fluorouracil 1 Doxorubicin 1 Cisplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02710734 2024-12-24

Risk Enabled Therapy After Initiating Neoadjuvant Chemotherapy for Bladder Cancer (RETAIN)

Fox Chase Cancer Center

Phase 2 Active not recruiting

Urothelial Carcinoma of the Bladder

Data powered by HemOnc (CC BY 4.0) Colophon ⚡